Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • EliG
    Junior Member
    • Aug 2009
    • 3

    #1

    Technical artefacts create supposed fake mosaics

    Dear community,

    In recent months, we have observed an increase in incidents in which we find de novo variants in the index in a trio (exome and genome) analysis and the variant is present in 1-2% of the reads in the parents.
    Due to the accumulation, we rather assume a technical artefact of Illumina sequencing (NovaSeq6000) where we cannot explain where it comes from.
    Do you also see something like this in your data or do you have an idea where it could come from?

    For the following reasons we assume a technical artefact and not a real parental mosaic:

    1. exclusion of cotamination of the parental samples by the child's DNA, because the samples were processed in different batches at different times.
    2. we see this in both exomes and genomes (PCR free) and conclude that it is not due to the lib prep.
    3. there are cases where both parents carry the same supposedly heterozygous de novo variant (in child) in the mosaic. This is extremely unlikely.

    Thank you very much for your input
    Best regards
    EliG

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:52 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...